Equity declined to $840.8 million from $914.4 million in 2026Q2, lowering the equity-to-assets ratio to 0.08 against a $10.2 billion asset base dominated by $9.1 billion of securities, or roughly 89% of total assets.
Amerant Bancorp Inc. (AMTB) balance sheet — 10-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 |
|---|
| Cash & Short Term Investments | 5.13B | 2.5B | 2B | 1.51B | 1.31B | 1.45B | 1.44B | 1.69B | 1.67B | 1.84B | 2.26B |
| Cash & Due from Banks | 361.47M | 470.15M | 565.99M | 296.02M | 248.44M | 274.21M | 214.39M | 121.32M | 85.71M | 153.44M | 134.99M |
| Short Term Investments | 2.17B | 2.02B | 1.44B | 1.22B | 1.06B | 1.18B | 1.23B | 1.57B | 1.59B | 1.69B | 2.12B |
| Total Investments | 9.11B | 8.65B | 8.63B | 8.62B | 8.15B | 6.79B | 7.04B | 7.36B | 7.53B | 7.78B | 7.81B |
| Investments Growth % | 15.18% | 0.22% | 0.12% | 5.75% | 19.96% | -3.52% | -4.34% | -2.27% | -3.18% | -0.38% | - |
| Long-Term Investments | 32.47B | 6.62B | 7.19B | 7.4B | 7.09B | 5.62B | 5.81B | 5.79B | 5.94B | 6.09B | 5.68B |
| Accounts Receivables | 0 | 0 | 0 | 0 | 156.01M | 92.5M | 93.77M | 66.89M | 73.65M | 73.08M | 70.03M |
| Goodwill & Intangibles | 0 | 19.19M | 19.19M | 19.19M | 19.51M | 19.51M | 19.51M | 19.51M | 19.19M | 19.19M | 19.19M |
| Goodwill | 0 | 19.19M | 19.19M | 19.19M | 19.51M | 19.51M | 19.51M | 19.51M | 19.19M | 19.19M | 19.19M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PP&E (Net) | 106.08M | 110.59M | 131.84M | 162.09M | 181.76M | 179M | 109.99M | 128.82M | 123.5M | 129.36M | 148.71M |
| Other Assets | 461.24M | 496.13M | 505.16M | 567.3M | 326.15M | 270.5M | 282.56M | 284.79M | 276.33M | 270.25M | 224.35M |
| Total Current Assets | 2.63B | 2.5B | 2B | 1.51B | 1.46B | 1.54B | 1.53B | 1.76B | 1.75B | 1.91B | 2.33B |
| Total Non-Current Assets | 7.58B | 7.28B | 7.9B | 8.2B | 7.67B | 6.1B | 6.24B | 6.23B | 6.38B | 6.52B | 6.11B |
| Total Assets | 10.21B | 9.78B | 9.9B | 9.72B | 9.13B | 7.64B | 7.77B | 7.99B | 8.12B | 8.44B | 8.43B |
| Asset Growth % | -6.18% | -1.26% | 1.91% | 6.45% | 19.5% | -1.7% | -2.69% | -1.71% | -3.7% | 0.03% | - |
| Return on Assets (ROA) | 0.72% | 0.53% | -0.16% | 0.34% | 0.76% | 1.47% | -0.02% | 0.64% | 0.55% | 0.51% | 0.28% |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 69.23M | 53.05M |
| Total Debt | 971.4M | 1.04B | 1B | 921.33M | 1.2B | 1.07B | 1.17B | 1.33B | 1.28B | 1.29B | 1.1B |
| Net Debt | 609.93M | 570.71M | 438.72M | 625.3M | 950.86M | 795.04M | 958.37M | 1.21B | 1.2B | 1.14B | 964.12M |
| Long-Term Debt | 857.47M | 923.41M | 838.8M | 798.16M | 1.06B | 932.65M | 1.17B | 1.33B | 1.28B | 1.29B | 1.05B |
| Short-Term Debt | 0 | 0 | 59.84M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50M |
| Other Liabilities | 153.75M | 2.01B | 151.96M | 164.07M | 178.57M | 106.41M | 83.07M | 66.31M | 60.13M | 0 | 0 |
| Total Current Liabilities | 8.25B | 5.79B | 7.91B | 7.89B | 7.04B | 5.63B | 5.73B | 5.76B | 6.03B | 6.39B | 6.68B |
| Total Non-Current Liabilities | 1.13B | 3.05B | 1.1B | 1.09B | 1.38B | 1.18B | 1.26B | 1.39B | 1.34B | 1.29B | 1.05B |
| Total Liabilities | 9.37B | 8.84B | 9.01B | 8.98B | 8.42B | 6.81B | 6.99B | 7.15B | 7.38B | 7.68B | 7.73B |
| Total Equity | 840.82M | 938.8M | 890.47M | 736.07M | 705.73M | 831.87M | 783.42M | 834.7M | 747.42M | 753.45M | 704.74M |
| Equity Growth % | -5.82% | 5.43% | 20.98% | 4.3% | -15.16% | 6.18% | -6.14% | 11.68% | -0.8% | 6.91% | - |
| Equity / Assets (Capital Ratio) | 8.23% | 9.6% | 8.99% | 7.58% | 7.73% | 10.89% | 10.08% | 10.45% | 9.2% | 8.93% | 8.36% |
| Return on Equity (ROE) | 8.03% | 5.73% | -1.94% | 4.51% | 8.23% | 13.98% | -0.21% | 6.49% | 6.11% | 5.91% | 3.35% |
| Book Value per Share | 21.32 | 22.84 | 24.90 | 21.86 | 20.67 | 22.17 | 18.77 | 19.44 | 17.59 | 21.58 | 20.18 |
| Tangible BV per Share | 21.32 | 22.37 | 24.37 | 21.29 | 20.10 | 21.65 | 18.30 | 18.98 | 17.14 | 21.03 | 19.63 |
| Common Stock | 3.91M | 4.06M | 4.21M | 3.36M | 3.38M | 3.59M | 3.79M | 4.67M | 4.46M | 4.25M | 12.75M |
| Additional Paid-in Capital | 282.45M | 316.07M | 343.83M | 192.7M | 194.69M | 262.51M | 305.57M | 419.05M | 385.37M | 367.5M | 359.01M |
| Retained Earnings | 673.33M | 619.55M | 582.23M | 610.8M | 590.38M | 553.17M | 442.4M | 444.12M | 393.66M | 387.83M | 343.68M |
| Accumulated OCI | -118.87M | -875K | -39.81M | -70.8M | -80.64M | 15.22M | 31.66M | 13.23M | -18.16M | -6.13M | -10.7M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -46.37M | -17.91M | 0 | 0 |
| Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying AMTB stock.
As of 2025, Amerant Bancorp Inc. (AMTB) had total assets of $9.78B including $2.50B in current assets.
Amerant Bancorp Inc. (AMTB) carries total debt of $1.04B. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Amerant Bancorp Inc. (AMTB) has total shareholders' equity (book value) of $938.8M ($22.84 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Amerant Bancorp Inc. (AMTB) reported a current ratio of 0.43x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Securities concentration and equity erosion
Metrics are mathematically derived from official filings.
Plateauing Assets With Softening Capital
Based on Amerant's reported balance sheets, total assets stood at $10.2 billion in 2026Q3, down from $10.4 billion a year earlier, while equity slipped to $840.8 million from $914.4 million, a combination that appears to signal modest contraction alongside capital softness.
Assets have oscillated between $9.7 billion and $10.4 billion across the ten quarters without establishing a sustained expansion path, which suggests the balance sheet is rotating internally rather than growing organically. The securities book expanded from $8.6 billion in 2024Q4 to $9.1 billion in 2026Q3 even as cash balances collapsed from $661.8 million to $361.5 million, implying asset growth quality is increasingly tied to portfolio positioning rather than loan demand. The reversal of the equity build from $734.3 million in 2024Q2 to $914.4 million in 2026Q2 warrants monitoring, as it may indicate that retained earnings and capital actions are no longer compounding the balance sheet.
Cash Buffers Swing Erratically
Amerant's liquidity position has been highly uneven, with cash and due from banks swinging from $41.0 million in 2026Q2 to $361.5 million in 2026Q3, per Amerant's reported figures, against a $9.1 billion securities book that dominates the asset side.
Cash has traversed $277.9 million, $661.8 million, $634.9 million, $470.2 million, $63.4 million, $41.0 million and $361.5 million over the period, a range too wide to reflect steady operating liquidity and more consistent with episodic deposit and securities movements. Against $9.4 billion of total liabilities, a $41.0 million cash position in 2026Q2 appears thin, meaning the bank's liquidity profile leans heavily on the monetizability of its securities holdings rather than a stable cash buffer. Because the supplied cash flow data shows mirrored securities purchases and sales across adjacent quarters, the true durability of this liquidity cushion warrants further investigation.
Provision Swings Cloud Credit Read
According to Amerant's quarterly disclosures, the loan loss provision swung from a $48.3 million release in 2026Q2 to a $6.2 million charge in 2026Q3, a reversal that obscures the underlying credit trajectory of the loan portfolio.
Prior quarters showed charges clustered between $3.5 million and $19.1 million, so the magnitude of the 2026Q2 release appears large enough to have materially flattered that period's earnings rather than reflecting a measurable improvement in credit performance. The abrupt return to a $6.2 million charge does not by itself establish deterioration, but the volatility makes reserve adequacy difficult to judge from reported figures alone, particularly given the bank's documented concentration in South Florida commercial real estate. Investors should monitor whether the allowance qualitative factors underlying the Florida CRE book are being recalibrated, since a single large release followed by renewed building would be consistent with reserve timing rather than a genuine turn in the credit cycle.
Capital Cushion Thins to Cycle Low
As reported in Amerant's balance sheet, equity declined to $840.8 million in 2026Q3 from $914.4 million in the prior quarter, pulling the equity-to-assets ratio down to 0.08, its weakest reading since 2024Q2 and leaving less apparent capital cushion against the bank's $10.2 billion asset base.
The equity-to-assets ratio held at 0.09 to 0.10 for most of the series, so the step-down to 0.08 alongside a $73.6 million equity decline in a single quarter appears to represent a meaningful, if not yet alarming, compression of the buffer. With ROE of just 2.9% in 2026Q3, internal capital generation appears modest relative to a dividend outflow near $3.7 million per quarter, which suggests that any resumed buyback activity would likely need to be funded from balance sheet repositioning rather than earnings. The supplied data does not decompose the equity decline between buybacks, dividends and accumulated other comprehensive income, so the source of the erosion warrants closer examination before assuming it is purely capital return.
NIM Stuck as NII Momentum Fades
Earnings from the loan book appear stuck, as net interest margin held between 0.8% and 0.9% across all ten reported quarters while net interest income fell to $90.5 million in 2026Q3, based on Amerant's income statements.
A ten-quarter NIM range this compressed suggests asset yields and funding costs are repricing in tandem, leaving little room for margin expansion regardless of which side of the balance sheet moves first. The year-over-year decline in NII to $90.5 million from $94.2 million in 2025Q3, occurring while total assets were essentially flat, implies that volume is no longer offsetting spread pressure. Because the supplied data does not disclose deposit composition or cost, the direction of margin recovery cannot be inferred here, and investors should monitor loan yields and funding costs in coming quarters for evidence of whether the 63.5% efficiency ratio improvement can translate into durable earnings.
Duration Risk Dominates the Balance Sheet
The most underappreciated exposure appears to be duration, given that securities of $9.1 billion represent roughly 89% of Amerant's $10.2 billion in total assets as of 2026Q3, according to Amerant's reported balance sheet, a concentration that may amplify mark-to-market swings.
An asset base so heavily weighted toward securities means that interest rate movements could affect the balance sheet through valuation and reinvestment effects far more than through loan credit, a risk that is easy to miss when attention centers on CRE concentration. Notably, the $73.6 million equity decline in 2026Q3 occurred alongside a $600 million reduction in the securities book from 2026Q2, which may indicate portfolio sales at realized or unrealized losses, though the supplied data does not isolate accumulated other comprehensive income and the precise driver warrants further investigation. If a meaningful portion of the equity decline reflects securities valuation rather than capital return, the market's read on Amerant's true capital position could prove understated in one direction or overstated in the other.